Physician
Kidney Care and Transplant Services of New England, PC
Kidney Care and Transplant Services of New England, PC was paid $2.10M by Medicaid between Jan 2018 and Nov 2024, across 36 billing codes. Its largest line is 90960, End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits — 26% of everything it billed.
33Billing provider infoKIDNEY CARE AND TRANSPLANT SERVICES OF NEW ENGLAND, PC
SPRINGFIELD, MA 01104
SPRINGFIELD, MA 01104
33aNPI1598202558assigned 01/27/2017
33bProvider typeSurgery Physician
28Total paid$2.10M
24GClaims72,256
24DCodes billed36
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Surgery Physician providers in Massachusetts
Rank by total paid#2 of 76
Median peer was paid$6K
This provider vs. median362×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,825 | $389K | |
| 2019 | 11,612 | $357K | |
| 2020 | 10,236 | $292K | |
| 2021 | 9,340 | $283K | |
| 2022 | 11,262 | $354K | |
| 2023 | 9,032 | $230K | |
| 2024incomplete | 7,949 | $192K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 26% | 10,215 | 9,960 | $550K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 13,009 | 12,186 | $460K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 17% | 21,547 | 8,343 | $354K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 12% | 1,703 | 862 | $242K |
| 36902 | 4.8% | 552 | 507 | $102K | |
| 99222 | Initial hospital care, per day, moderate complexity | 4.7% | 3,240 | 3,016 | $99K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 2.3% | 911 | 369 | $48K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.1% | 1,695 | 1,512 | $44K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 1.7% | 2,049 | 968 | $36K |
| 90961 | 1.6% | 533 | 512 | $34K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.3% | 807 | 268 | $28K |
| 99223 | Prolong inpt eval add15 m | <1% | 341 | 319 | $20K |
24 more codes
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 2,213 | $17K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,912 | $16K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,083 | $15K |
| 99442 | <1% | 780 | $9K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 159 | $9K |
| 99152 | <1% | 1,182 | $4K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 644 | $2K |
| 90966 | <1% | 24 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 218 | $1K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,193 | $1K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $1K |
| 96409 | <1% | 14 | $792.14 | |
| 85018 | <1% | 947 | $775.35 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,797 | $501.66 |
| 90756 | <1% | 67 | $413.17 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 18 | $394.76 |
| 0013A | <1% | 18 | $280.00 | |
| 0003A | <1% | 16 | $160.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 229 | $140.69 |
| 99441 | <1% | 17 | $67.55 | |
| 90970 | <1% | 68 | $15.36 | |
| 91301 | 0% | 18 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 12 | $0.00 |
| 91300 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMULHERN, JEFFREY (PRESIDENT)